Loading clinical trials...
Loading clinical trials...
An Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 to Evaluate the Long-Term Safety and Effectiveness of CIN-107
Conditions
Interventions
CIN-107
Locations
36
United States
Research Site
Saraland, Alabama, United States
Research Site
Huntington Park, California, United States
Research Site
Lincoln, California, United States
Research Site
Los Angeles, California, United States
Research Site
Northridge, California, United States
Research Site
Oceanside, California, United States
Start Date
April 6, 2022
Primary Completion Date
November 7, 2023
Completion Date
November 7, 2023
Last Updated
December 16, 2024
NCT07439939
NCT05746039
NCT02417740
NCT04454203
NCT03854071
NCT07480265
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions